Pfizer Inc-BioNTech’s COVID-19 vaccine was 93% effective in preventing hospitalizations in people ages 12 to 18, said a statement from the US Centers for Disease Control and Prevention ( CDC) on Tuesday.
The study was conducted between June and September, when the extremely contagious Delta variant of the coronavirus predominated.
However, data from 19 pediatric hospitals showed that among the 179 patients who were hospitalized for COVID-19, 97% were not vaccinated, providing assurance about the efficacy of the vaccine.
Of the 16% of hospitalized patients with COVID-19 severe enough to require life support, none were vaccinated.
The report of the CDC is based on trials conducted by companies in this age group that showed a high immune response against the virus, but were not designed to demonstrate efficacy against hospitalization.
The vaccine Pfizer-BioNTech It is licensed for children up to 12 years of age, and companies are seeking authorization for its use in children up to five years of age.
A panel of advisory experts from the US Food and Drug Administration is expected to evaluate the data on young children later this month.
The data of the CDC “Reinforce Importance of Vaccination to Protect Young Americans Against Severe COVID-19”Said the study authors.
.
Ricardo is a renowned author and journalist, known for his exceptional writing on top-news stories. He currently works as a writer at the 247 News Agency, where he is known for his ability to deliver breaking news and insightful analysis on the most pressing issues of the day.
